Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 1994BloodOpen Access

2-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disorders

View Full Paper
Ask AI
Bookmark
Share

Authors

SOStephen O’BrienHospital for Special SurgeryRazelle KurzrockRazelle KurzrockFroedtert HospitalMDMadeleine DuvicThe University of Texas MD Anderson Cancer Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

O’Brien et al. (1994) studied this question.

synapsesocial.com/papers/6a7119f3abc331a85807a452https://doi.org/10.1182/blood.v84.3.733.733
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mycosis fungoides: clinical and histologic features, staging, evaluation, and approach to treatment1993 · 72 citations
  2. 2Fludarabine: a new agent with major activity against chronic lymphocytic leukemia1989 · 454 citations
  3. 3Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working group1988 · 406 citations
  4. 4Peripheral T-Cell Lymphoma: Aggressive Disease with Heterogeneous Immunotypes1985 · 161 citations
  5. 5Chronic Lymphocytic Leukaemia of T Cell Origin1983 · 17 citations